Axel Jair Villa-Panduro , Narda M. Corona-Reynaga , Dennis A. Meza-Peña , Mayra Alejandra Enciso Ramírez , Astrid Selene Espinoza García , Jorge Galindo-García , Berenice Sanchez-Caballero , Elia Herminia Valdés-Miramontes , José Francisco Muñoz-Valle , Zyanya Reyes-Castillo
{"title":"TNF 基因变异 rs1800629 和 IL6R 基因变异 rs2228145：与墨西哥西部接种过 AZD1222 疫苗的人群中免疫接种和疫苗接种所致事件 (VACE) 以及针对 SARS-CoV-2 的中和抗体有关。","authors":"Axel Jair Villa-Panduro , Narda M. Corona-Reynaga , Dennis A. Meza-Peña , Mayra Alejandra Enciso Ramírez , Astrid Selene Espinoza García , Jorge Galindo-García , Berenice Sanchez-Caballero , Elia Herminia Valdés-Miramontes , José Francisco Muñoz-Valle , Zyanya Reyes-Castillo","doi":"10.1016/j.vacun.2023.12.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>In this research, we evaluated the association of genetic variants rs1800629 in <em>TNF</em> and rs2228145 in <em>IL6R</em> with production of neutralizing antibodies against SARS-CoV-2 and the frequency of adverse effects following immunization (AEFIs) in adult population from Western of Mexico that received AZD1222 vaccination.</p></div><div><h3>Methods</h3><p>One hundred-seventeen adults were evaluated (33 years [23-40], 65% women). The self-reported frequency of AEFIs was recorded and the percentage of post-vaccination neutralizing antibodies was quantified. The identification of rs1800629 variant in <em>TNF</em> and rs2228145 in <em>IL6R</em> was performed by qPCR.</p></div><div><h3>Results</h3><p>The genotype frequencies of rs1800629 variant were: GG (86%) and GA (14%), and for rs2228145 variant were: AA (20%), CA (48%) and CC (32%). The percentage of post-vaccination antibodies was similar between men and women (median, 97.24%). An association was found between the frequency of AEFIs with the sex; being adynamia (<em>p</em> <!-->=<!--> <!-->0.0243), chills (<em>p</em> <!-->=<!--> <!-->0.0085), arthralgia (<em>p</em> <!-->=<!--> <!-->0.0227) and pain in application area (<em>p</em> <!-->=<!--> <!-->0.0096) more frequent in women. The GA genotype of rs1800629 variant showed an association with fever (<em>p</em> <!-->=<!--> <!-->0.0131) and arthralgia (<em>p</em> <!-->=<!--> <!-->0.0058) post-vaccination, but no relationship was found with the production of neutralizing antibodies after AZD1222 vaccination. The rs2228145 variant was not associated with the production of antibodies nor with the AEFIs reported.</p></div><div><h3>Conclusion</h3><p>The genetic variants rs1800629 in <em>TNF</em> and rs222815 in <em>IL6R</em> are not associated with the production of neutralizing antibodies against SARS-CoV-2 after receiving AZD1222 scheme in population from western of Mexico; however, the results suggest that rs1800629 variant increases the frequency of post-vaccination events, particularly fever and arthralgia.</p></div>","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Variantes genéticas rs1800629 en TNF y rs2228145 en IL6R: asociación con eventos supuestamente atribuibles a la vacunación e inmunización (ESAVI) y anticuerpos neutralizantes contra SARS-CoV-2 en la población del occidente de México vacunada con AZD1222\",\"authors\":\"Axel Jair Villa-Panduro , Narda M. Corona-Reynaga , Dennis A. Meza-Peña , Mayra Alejandra Enciso Ramírez , Astrid Selene Espinoza García , Jorge Galindo-García , Berenice Sanchez-Caballero , Elia Herminia Valdés-Miramontes , José Francisco Muñoz-Valle , Zyanya Reyes-Castillo\",\"doi\":\"10.1016/j.vacun.2023.12.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>In this research, we evaluated the association of genetic variants rs1800629 in <em>TNF</em> and rs2228145 in <em>IL6R</em> with production of neutralizing antibodies against SARS-CoV-2 and the frequency of adverse effects following immunization (AEFIs) in adult population from Western of Mexico that received AZD1222 vaccination.</p></div><div><h3>Methods</h3><p>One hundred-seventeen adults were evaluated (33 years [23-40], 65% women). The self-reported frequency of AEFIs was recorded and the percentage of post-vaccination neutralizing antibodies was quantified. The identification of rs1800629 variant in <em>TNF</em> and rs2228145 in <em>IL6R</em> was performed by qPCR.</p></div><div><h3>Results</h3><p>The genotype frequencies of rs1800629 variant were: GG (86%) and GA (14%), and for rs2228145 variant were: AA (20%), CA (48%) and CC (32%). The percentage of post-vaccination antibodies was similar between men and women (median, 97.24%). An association was found between the frequency of AEFIs with the sex; being adynamia (<em>p</em> <!-->=<!--> <!-->0.0243), chills (<em>p</em> <!-->=<!--> <!-->0.0085), arthralgia (<em>p</em> <!-->=<!--> <!-->0.0227) and pain in application area (<em>p</em> <!-->=<!--> <!-->0.0096) more frequent in women. The GA genotype of rs1800629 variant showed an association with fever (<em>p</em> <!-->=<!--> <!-->0.0131) and arthralgia (<em>p</em> <!-->=<!--> <!-->0.0058) post-vaccination, but no relationship was found with the production of neutralizing antibodies after AZD1222 vaccination. The rs2228145 variant was not associated with the production of antibodies nor with the AEFIs reported.</p></div><div><h3>Conclusion</h3><p>The genetic variants rs1800629 in <em>TNF</em> and rs222815 in <em>IL6R</em> are not associated with the production of neutralizing antibodies against SARS-CoV-2 after receiving AZD1222 scheme in population from western of Mexico; however, the results suggest that rs1800629 variant increases the frequency of post-vaccination events, particularly fever and arthralgia.</p></div>\",\"PeriodicalId\":53407,\"journal\":{\"name\":\"Vacunas\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vacunas\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1576988724000013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vacunas","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1576988724000013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Variantes genéticas rs1800629 en TNF y rs2228145 en IL6R: asociación con eventos supuestamente atribuibles a la vacunación e inmunización (ESAVI) y anticuerpos neutralizantes contra SARS-CoV-2 en la población del occidente de México vacunada con AZD1222
Introduction
In this research, we evaluated the association of genetic variants rs1800629 in TNF and rs2228145 in IL6R with production of neutralizing antibodies against SARS-CoV-2 and the frequency of adverse effects following immunization (AEFIs) in adult population from Western of Mexico that received AZD1222 vaccination.
Methods
One hundred-seventeen adults were evaluated (33 years [23-40], 65% women). The self-reported frequency of AEFIs was recorded and the percentage of post-vaccination neutralizing antibodies was quantified. The identification of rs1800629 variant in TNF and rs2228145 in IL6R was performed by qPCR.
Results
The genotype frequencies of rs1800629 variant were: GG (86%) and GA (14%), and for rs2228145 variant were: AA (20%), CA (48%) and CC (32%). The percentage of post-vaccination antibodies was similar between men and women (median, 97.24%). An association was found between the frequency of AEFIs with the sex; being adynamia (p = 0.0243), chills (p = 0.0085), arthralgia (p = 0.0227) and pain in application area (p = 0.0096) more frequent in women. The GA genotype of rs1800629 variant showed an association with fever (p = 0.0131) and arthralgia (p = 0.0058) post-vaccination, but no relationship was found with the production of neutralizing antibodies after AZD1222 vaccination. The rs2228145 variant was not associated with the production of antibodies nor with the AEFIs reported.
Conclusion
The genetic variants rs1800629 in TNF and rs222815 in IL6R are not associated with the production of neutralizing antibodies against SARS-CoV-2 after receiving AZD1222 scheme in population from western of Mexico; however, the results suggest that rs1800629 variant increases the frequency of post-vaccination events, particularly fever and arthralgia.
期刊介绍：
Sin duda una de las mejores publicaciones para conocer los avances en el campo de las vacunaciones preventivas, tanto en el ámbito de la investigación básica como aplicada y en la evaluación de programas de vacunaciones. Su alta calidad y utilidad la ha llevado a estar indexada en los prestigiosos índices IME y SCOPUS.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
